Lucitanib
CAS: 1058137-23-7
Ref. 3D-ISB13723
| 1mg | A consultar | |
| 5mg | A consultar | |
| 10mg | A consultar | |
| 25mg | A consultar | |
| 50mg | A consultar |
Información del producto
Lucitanib is a potent anti-tumor agent that inhibits the growth of cancer cells by inhibiting the production of vascular endothelial growth factor receptor 1 (VEGFR1). It also has antiangiogenic properties. Lucitanib has been shown to inhibit the proliferation of cancer cells in vitro and in vivo. A mouse tumor model was used to study the effects of lucitanib, which showed a significant inhibition of tumor size. In addition, lucitanib inhibited IL-2 receptor expression, leading to an increase in apoptosis of T lymphocytes and natural killer cells. The drug also showed potent antitumor activity against carcinoma cell lines in vitro. The LC-MS/MS method was used for identification and quantification of lucitanib in biological samples from breast cancer patients.
Propiedades químicas
Consulta técnica sobre: 3D-ISB13723 Lucitanib
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
